bioinformatics jobs, bioinformatics career, what is bioinformatics, biotech companies, pharmaceutical companies, etc.

::Bioinformatics Resources::

Home News Companies Tutorials Books Jobs Resources What's Bioinformatics Bioinformatics FAQ

Bioinformatics News 07/2008 (Page 4)

Wikipedia opens online library on human genes (AFP via Yahoo! News)
A group of US researchers laid out the foundations Monday for a new online library on human genetics stored within the existing framework of open-access encyclopedia Wikipedia.

Incubator looks to give tech companies a start (St. Louis Post-Dispatch)
The first tenant is moving into IT Enterprises, UMSL's new high-performance computing center and business incubator, which has room for a dozen firms.

Genetic web library opens (iafrica.com)
A group of US researchers have opened a online library of the human genome.

BGI signs global site license pact with CLC bio for sequencing solution (PharmaBiz)
Beijing Genomics Institute (BGI) has signed a global site license agreement for CLC bio's Next Generation Sequencing solution, CLC Genomics Workbench. The site license covers all researchers at all BGI sites, both inside and outside of China.

My Pharmiweb.com (PharmiWeb)
AnaSpec Introduces New Series of PAR Peptides AnaSpec Inc. Posted on:07 Jul 08 San Jose, CA – July 7, 2008 AnaSpec, one of the world’s largest providers of catalog peptides, has introduced its latest series of PAR peptides.

Significant Impact Factor Boost For Scientific Journal Genome Research (Medical News Today)
Earlier this month, ThomsonReuters released the 2007 Journal Citation Reports, which includes impact factors for the world's most important scholarly journals. The scientific journal Genome Research, published by Cold Spring Harbor Laboratory Press, was reported with an impact factor of 11.224, a considerable gain over 10.256 in 2006.

Illumina to Announce Second Quarter 2008 Financial Results on Tuesday, July 22, 2008 (Centre Daily Times)
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2008 following the close of market on Tuesday, July 22, 2008.

Yale Keck Microarray Center Becomes a GeneGo Center of Excellence (PR Newswire via Yahoo! Finance)
GeneGo, Inc., the leading systems biology tools company, announced today that Keck Microarray Center at Yale has become a certified GeneGo Center of Excellence . Yale researchers will have access to GeneGo's MetaCore, training and advanced support.

Unilever Extends Their GeneGo MetaCore License (PR Newswire via Yahoo! Finance)
GeneGo, Inc., the leading systems biology tools company, announced today that Unilever extended its license to GeneGo products. Unilever uses systems analysis tools for research in its consumer goods and skin care product development.

Tools For The Rosaceae Genomics Community Provided By Review Article (Medical News Today)
A recent paper published in the journal Plant Physiology provides a comprehensive overview of the genomics tools and resources available for the rapidly growing Rosaceae scientific community. Rosaceae is an economically important group of plants that comprises more than 3,000 species, including strawberry, apple, peach and pear.

How To Check Yourself For Abnormal Genes (Slashdot)
AnneWoahHickey writes "While the State of California was harassing personalized genomics companies, and hindering the development of personalized medicine, Wired was preparing a guide to genetic testing. It explains how to make sense of the massive sets of raw data offered by 23andMe or deCODEme, and a way to check yourself for genetic abnormalities that are not covered by microarray tests. ...

Quantum Genomics Corp Signs Strategic Agreement With PCAS To Make First Batch of Hypertension Drug Candidate (Business Wire via Yahoo! Finance)
JERSEY CITY, N.J.----Quantum Genomics Corp. , a global biotech company developing new drugs for metabolic and cardiovascular diseases, today announced a strategic agreement for the manufacture of the first batch of its QCC001 drug candidate for hypertension.

Genome Sequencer FLX System plus NimbleGen Sequence Capture Arrays Help Unravel the Cryptic Genetic Changes in ... (Business Wire via Yahoo! Finance)
PENZBERG, Germany----The Cancer Genomics Group at Barts and The London Medical School is researching leukemia with the aquisition of the state-of-the-art Genome Sequencer FLX System paired with the Roche NimbleGen Sequence Capture arrays.

Ivy Foundation Funds New Brain Cancer Research Consortium (Business Wire via Yahoo! Finance)
PALO ALTO, Calif.----Today, the Ben and Catherine Ivy Foundation , a newly formed family foundation dedicated to improving survival and quality of life for patients with brain tumors, announced funding for the Ivy Genomics-Based Medicine Project.

posted by Edward H. Trager on Mon 1st Dec 2003 07:38 UTC (New Mobile Computing)
I work in a genetics research laboratory at an academic institution. Recently, a colleague of mine was having a lot of trouble with his Windows 2000 workstation.

Quantum Genomics Corp Signs Strategic Agreement With PCAS To Make First Batch of Hypertension Drug Candidate (Centre Daily Times)
Quantum Genomics Corp. (QGC), a global biotech company developing new drugs for metabolic and cardiovascular diseases, today announced a strategic agreement for the manufacture of the first batch of its QCC001 drug candidate for hypertension. The agreement is with PCAS Pharma Synthesis, a world-class supplier of key intermediates and bulk actives to the pharmaceutical industry.

Affymetrix and Asuragen Sign Agreement to Develop IVT Reagent Kits for Molecular Diagnostic Applications (Centre Daily Times)
Affymetrix Inc. (NASDAQ:AFFX) and Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to license, develop and manufacture in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications.

Ivy Foundation Funds New Brain Cancer Research Consortium (Centre Daily Times)
Today, the Ben and Catherine Ivy Foundation (Ivy Foundation), a newly formed family foundation dedicated to improving survival and quality of life for patients with brain tumors, announced funding for the Ivy Genomics-Based Medicine Project.

FDA Grants Invitrogen Premarket Approval of Breast Cancer Test (Business Wire via Yahoo! Finance)
CARLSBAD, Calif.----Invitrogen Corporation, , a provider of essential life science technologies for research, production and diagnostics, today announced it has received U.S. Food and Drug Administration premarket approval for its SPOT-Light® HER2 CISH Kit, indicated as an aid in the assessment of breast cancer patients for whom trastuzumab treatment is being considered.

Rare Microorganism That Produces Hydrogen May Be Key To Tomorrow's Hydrogen Economy (Science Daily)
An ancient organism from the pit of a collapsed volcano may hold the key to tomorrow's hydrogen economy. Scientists from across the world have formed a team to unlock the process refined by a billions-year old archaea. This novel hyperthermophilic archaea grows best at 80 to 82 degrees Celsius (176-180 Farenheit), close to the boiling point of water.

Power3 Medical Products, Inc. Provides Progress Report - NuroPro(R) Clinical Validation Study of Serum Biomarkers for ... (Centre Daily Times)
Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company specializing in the development and commercialization of diagnostic tests for early detection of breast cancer and neurodegenerative diseases, is providing an interim status report of its international validation study of the company's NuroPro(R) blood serum biomarker test for Parkinson's disease.

Can You Hear Me Now? Primitive Single-Celled Microbe Expert In Cellular Communication Networks (Science Daily)
When it comes to cellular communication networks, a primitive single-celled microbe that answers to the name of Monosiga brevicollis has a leg up on animals composed of billions of cells. It commands a signaling network more elaborate and diverse than found in any multicellular organism higher up on the evolutionary tree, researchers at the Salk Institute for Biological Studies have discovered.

Rare hydrogen producing microorganism may help unlock tomorrow's hydrogen economy (Environmental News Network)
An ancient organism from the pit of a collapsed volcano may hold the key to tomorrow's hydrogen economy. Scientists from across the world have formed a team to unlock the process refined by a billions-year old archaea. The U.S. Department of Energy Joint Genome Institute will expedite the research by sequencing the hydrogen-producing organism for comparative genomics.

Affymetrix, Asuragen collaborate on in vitro reagent kits (Silicon Valley - San Jose Business Journal)
Affymetrix Inc. and Asuragen Inc. on Tuesday announced an agreement to license, develop and manufacture in vitro transcription reagent kits for clinical molecular diagnostic applications. (AFFX)

DTC Genomics Firms Respond to Range of Concerns at Fed-Sponsored Roundtable (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.

New bioinformatics software created (UPI)
SAN DIEGO, July 8 (UPI) -- A team of U.S. university undergraduates says it's created a new area of bioinformatics that might lead to improved genomic and proteomic annotations.

New bioinformatics software created (Moldova.org)
A team of U.S. university undergraduates says it's created a new area of bioinformatics that might lead to improved genomic and proteomic annotations.The group of University of California-San Diego students said the new area of bioinformatics is called comparative proteogenomics, combining the fields of comparative genomics and proteomics, which is the study of all of an organism's proteins.This ...

New bioinformatics software created (Moldova.org)
A team of U.S. undergraduate students says it has created a method using information about proteins to identify the location and function of specific genes.The group of University of California-San Diego students said the new area of bioinformatics is called comparative proteogenomics, combining the fields of comparative genomics and proteomics, which is the study of all of an organism's ...

Protein marker for schizophrenia risk (EurekAlert!)
A protein found in immune cells may be a reliable marker for schizophrenia risk, report researchers in a new proteomics study appearing in the July issue of Molecular and Cellular proteomics.

Switzerland trip for computer study (Long Beach Press-Telegram)
Ten computer engineering and computer science students from Cal State Long Beach will travel to Switzerland as part of an American contingent participating in the Swiss Computer Science Summer Program.

French Bioinformatics Firm Ariana Pharma Raises $2.3M in VC Funding (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.

GeneGo Certifies Yale Microarray Center as 'Center of Excellence,' Extends License with Unilever (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.

UAB joins elite brain cancer research group (News-Medical-Net)
Brain cancer experts at the University of Alabama at Birmingham (UAB) have been selected for membership in the Ivy Genomics-Based Medicine Project. The project is a national consortium of cutting-edge hospitals and academic centers working to improve treatment and survival for patients with a kind of malignant brain tumor called a glioma.

Invitrogen Sets Second Quarter Earnings Release Date for Thursday, July 24, 2008 (Business Wire via Yahoo! Finance)
CARLSBAD, Calif.----Invitrogen Corporation , a provider of essential life science technologies for research, production and diagnostics, will announce its second quarter 2008 earnings on Thursday, July 24, 2008, before Market open.

Protein found in immune cells may be a reliable marker for schizophrenia risk (News-Medical-Net)
Schizophrenia is a severe and complex psychiatric illness that affects about 1% of the population. Diagnosis currently relies on subjective clinical interviews and the assessment of ambiguous symptoms, which frequently leads to delayed diagnosis and treatment. As such, biomarkers that would indicate schizophrenia risk or onset would be extremely useful.

posted by David W. Kuhn on Fri 10th Jun 2005 16:34 UTC (New Mobile Computing)
Was it Palol Rossetti that one said, "People in glass house shouldn't throw stones?” Push away the Intel this, the Pentium-M that, or perhaps the ability to use the Dual Core Pentium 4, Apple has a much bigger challenge ahead of them. For years, they have been throwing down the MHz myth and now?

Rare Microorganism May Be Key To Hydrogen Economy (Fuel Cell Today)
An ancient organism from the pit of a collapsed volcano may hold the key to tomorrow's hydrogen economy. Scientists from across the world have formed a team to unlock the process refined by a billions-year old archaea.

Scientists uncover protein biomarker for schizophrenia risk (New Kerala)
Washington, July 9 : Neuroscientists at the UK-based University of Cambridge say that a protein found in immune cells may be a reliable marker for schizophrenia risk.

The MIT Enterprise Forum Appoints Richard Kivel, CEO of TheraGenetics, as Chairman of Global Board of Directors (Business Wire via Yahoo! Finance)
CAMBRIDGE, Mass.----The MIT Enterprise Forum, Inc. announced today that Richard Kivel, a serial entrepreneur who serves as CEO of personalized medicine diagnostics company TheraGenetics, has been appointed the new Chairman of its Global Board of Directors.

Protein Marker For Schizophrenia Risk (Medical News Today)
A protein found in immune cells may be a reliable marker for schizophrenia risk, report researchers in a new proteomics study appearing in the July issue of Molecular and Cellular proteomics. Schizophrenia is a severe and complex psychiatric illness that affects about 1% of the population.

Spellex Releases Spellex Biotech V.2008, New Upgrade Of The World's First Bioscience Spell Checking Software (Medical News Today)
Spellex Corporation announces the new release of the 2008 version of their popular bioscience spelling software for Microsoft and other programs. The new release includes more than 210,000 specialty words from the bioscience industry and new spelling engine enhancements. Benefits: The Spellex Biotech spelling dictionary allows users to save time and increase their accuracy.

Hepatitis C Virus May Need Help Of Enzyme To Cause Liver Disease, Pitt Study Finds (Medical News Today)
A key enzyme may explain how hepatitis C infection causes fatty liver - a buildup of excess fat in the liver, which can lead to life-threatening diseases such as cirrhosis and liver cancer, report University of Pittsburgh Graduate School of Public Health and School of Medicine researchers.

Cell prcessor trio extend R&D with Georgia Tech (EETimes)
IBM, Toshiba and Sony are to continue working on the Cell processor with researchers at the Georgia Tech College of Computing.

Cell processor trio extend R&D with Georgia Tech (EETimes)
IBM, Toshiba and Sony are to continue working on the Cell processor with researchers at the Georgia Tech College of Computing.

Cell prcessor trio extend R&D with Georgia Tech (EETimes)
IBM, Toshiba and Sony are to continue working on the Cell processor with researchers at the Georgia Tech College of Computing.

Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic ... (PR Newswire via Yahoo! Finance)
Rosetta Genomics, Ltd. , a leader in the development of microRNA-based diagnostic and therapeutic products, announced today that the results of a study conducted by its scientists and collaborators and describing the use of microRNAs in accurately differentiating primary from metastatic tumors of the brain, have been published online in the peer-reviewed journal Brain Pathology.

Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic ... (PR Newswire via Yahoo! Finance)
Rosetta Genomics, Ltd. , a leader in the development of microRNA-based diagnostic and therapeutic products, announced today that the results of a study conducted by its scientists and collaborators and describing the use of microRNAs in accurately differentiating primary from metastatic tumors of the brain, have been published online in the peer-reviewed journal Brain Pathology.

posted by David W. Kuhn on Fri 10th Jun 2005 16:34 UTC (OS News)
Was it Palol Rossetti that one said, "People in glass house shouldn't throw stones?” Push away the Intel this, the Pentium-M that, or perhaps the ability to use the Dual Core Pentium 4, Apple has a much bigger challenge ahead of them. For years, they have been throwing down the MHz myth and now?

Hepatitis C virus may need enzyme's help to cause liver disease (EurekAlert!)
PITTSBURGH, July 9 – A key enzyme may explain how hepatitis C infection causes fatty liver – a buildup of excess fat in the liver, which can lead to life-threatening diseases such as cirrhosis and liver cancer, report University of Pittsburgh Graduate School of Public Health and School of Medicine researchers.

UAB Joins Elite Brain Cancer Group (Newswise)
The Ivy Genomics-Based Medicine Project is designed to improve treatment for malignant brain tumors by striving to unravel the genetic differences between gliomas. Consortium members like UAB will categorize tumors using sophisticated molecular profiling and, for the first time, test each tumor against a wide spectrum of treatments to match DNA markers with cancer-fighting response.


long term care insurance policy | diet center | find attorney



Bioinformatics News Archive
Home News Companies Tutorials Books Jobs Resources What's Bioinformatics Bioinformatics FAQ
© Copyright by ColorBasePair.com. All rights reserved.